New targetable form of disease revealed by responses with crizotinib in MET-amplified lung cancer
6/03/2014
A study presented at the American Society of Clinical Oncology (ASCO) Annual Meeting 2014 reports the results of a first-in-human, phase 1 dose escalation trial of crizotinib (XALKORI) in 14 patients...
Promising response to new combination therapy by patients with metastatic colon cancer
6/03/2014
In an aggressive disease known for poor response rates, researchers from The University of Texas MD Anderson Cancer Center found patients with advanced colorectal cancer responded well to a...
Discovery of possible basis for treating circadian clock disorders and associated metabolic problems
6/03/2014
Structural biologists have made important progress towards better understanding the functioning of the circadian clock.
Advanced bladder cancer patients benefit from immune therapy
6/03/2014
A multi-center phase I study using an investigational drug for advanced bladder cancer patients who did not respond to other treatments has shown promising results in patients with certain tumor...
It is estimated that there will be nearly 19 million cancer survivors in the U.S by 2024
6/03/2014
The number of cancer survivors in the United States, currently estimated to be 14.5 million, will grow to almost 19 million by 2024, according to an updated report by the American Cancer Society.
Potential dangers of chemotherapy regimen for bladder cancer patients uncovered by trial
6/03/2014
Patients with muscle-invasive bladder cancer often benefit from chemotherapy before surgery to remove the tumor, but a test of one regimen by researchers at Fox Chase Cancer Center was halted when...
New clinical guidelines for cancer-related fatigue
6/03/2014
Fatigue is a debilitating problem for cancer patients undergoing treatment; however, it also poses a huge detriment after treatment and can significantly affect quality of life.
More patients with ovarian cancer are receiving chemotherapy before surgery
6/03/2014
The use of chemotherapy before surgery to remove ovarian cancer has increased dramatically in recent decades, particularly among certain patients, according to a new analysis from Fox Chase Cancer...
In patients with pancreatic or ovarian cancer, phase I study of DMOT4039A
6/03/2014
A study presented at the 50th Annual Meeting of the American Society for Clinical Oncology (ASCO) describes the results of a phase I clinical trial of the investigational agent DMOT4039A against...
More than a quarter of HIV+ patients are also infected with the Hepatitis C virus (HCV), which may complicate treatment and care decisions after a cancer diagnosis.